Respi4Doctors is een digitaal platform waarop AstraZeneca informatie en diensten omtrent de behandeling van respiratoire aandoeningen aanbiedt.

The paradoxes of asthma management: time for a new approach?

Despite progress in asthma management, several studies confirm that when symptoms worsen, most patients simply increase their use of SABA and are less likely to increase use of their controller medication.1

In a recent publication from O’Byrne et al. published in the European Respiratory Journal1, international experts hypothesize that this pattern of SABA over-reliance is attributable to several paradoxes in our treatment approach and advice, which are confusing to patients. They also propose potential solutions to these paradoxes. 

This slide kit provides more details on this recent publication from the European Respiratory Journal.

1. O’Byrne et al. Eur Respir J 2017; 50: 1701103

Preview

Scroll here